Citation 153967

EZAKI,N: MIYADOH,S: HISAMATSU,T: KASAI,T: YAMADA,Y:. (1980). BN-183B-A NEW ANTITUMOR ANTIBIOTIC PRODUCED BY PSEUDOMONAS.TAXONOMY,ISOLATION,PHYSICO-CHEMICAL AND BIOLOGICAL PROPERTIES.. 33()

Citation Details

TitleBN-183B-A NEW ANTITUMOR ANTIBIOTIC PRODUCED BY PSEUDOMONAS.TAXONOMY,ISOLATION,PHYSICO-CHEMICAL AND BIOLOGICAL PROPERTIES.
AuthorsEZAKI,N: MIYADOH,S: HISAMATSU,T: KASAI,T: YAMADA,Y:
Year1980
Volume33
Issue

Summary

Year: 1980

Journal: Unknown

Organisms and Their Experiments (1)

Pseudomonas species (PSEUDOMONADACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
TOXICITY ASSESSMENT(QUANTITATIVE)
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
.
2
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
PSEUDOMAONAS ANTIBIOTIC BN-183-B
.
3
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
PSEUDOMAONAS ANTIBIOTIC BN-183-B
.
4
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
PSEUDOMAONAS ANTIBIOTIC BN-183-B
.
5
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
PSEUDOMAONAS ANTIBIOTIC BN-183-B
.
6
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
7
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
8
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
9
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
10
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
11
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
12
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
13
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
14
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
15
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
16
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
17
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
18
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
19
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
20
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
21
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
22
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
23
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
24
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
25
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
26
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
ACTIVE
27
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
WEAK ACTIVITY
28
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
WEAK ACTIVITY
29
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
WEAK ACTIVITY
30
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
WEAK ACTIVITY
31
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
32
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
33
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
34
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
35
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
36
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
37
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
38
MUTAGENIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROCARCINOGENIC DATA (MARKER CODE)
PSEUDOMAONAS ANTIBIOTIC BN-183-B
INACTIVE
Show SPARQL Queries (1)